-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SG-2501 in Primary Systemic Amyloidosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SG-2501 in Primary Systemic Amyloidosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.SG-2501 in Primary Systemic AmyloidosisDrug Details: SG-2501 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SG-2501 in Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SG-2501 in Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.SG-2501 in Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) Drug Details: SG-2501 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SG-2501 in Chronic Lymphocytic Leukemia (CLL)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SG-2501 in Chronic Lymphocytic Leukemia (CLL) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.SG-2501 in Chronic Lymphocytic Leukemia (CLL) Drug Details: SG-2501 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SG-2501 in Diffuse Large B-Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SG-2501 in Diffuse Large B-Cell Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.SG-2501 in Diffuse Large B-Cell Lymphoma Drug Details: SG-2501 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SG-2501 in Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SG-2501 in Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.SG-2501 in Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Drug Details: SG-2501...
-
Company Insights
Carrefour S.A – Digital Transformation Strategies
Carrefour Digital Transformation Strategies Overview Carrefour has been focusing on using e-commerce, artificial intelligence, cloud, and blockchain technologies to digitally transform its operations. The annual ICT spending of Carrefour was estimated at $1.9 billion for 2023. A major share of this spending is earmarked for acquiring software, ICT services, and hardware from vendors. Carrefour is a global consumer goods retailer that operates multi-format and omni-channel retail platforms. The company owns and operates a wide network of hypermarkets, supermarkets, convenience stores,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tusamitamab Ravtansine in Cervical Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Tusamitamab Ravtansine in Cervical Cancer Drug Details: Tusamitamab ravtansine is under development for the treatment of...
-
Product Insights
Bang Bo Combined Cycle Power Plant
Bang Bo Combined Cycle Power Plant is a thermal project located in Samut Prakan, Thailand. The project is owned by GMS Power Public Co Ltd; SG Bang Bo Power Holding Co Ltd; Tokyo Gas Asia Pte Ltd and was developed by GMS Power Public Co Ltd. The project came online in 2003. Empower your strategies with our Bang Bo Combined Cycle Power Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered...
-
Company Insights
Top Business and Professional Services Foreign Direct Investment Companies
Top Business and Professional Services Foreign Direct Investment Companies report analyzes the most active greenfield FDI investors globally (based on number of projects) in the Business and Professional Services sector between Q1 2019 and Q1 2024. Additionally, the report highlights where these top Business and Professional Services investors are investing in what type of operations. The report also provides an overview of notable FDI projects from these top investors. The report will be delivered within 2-3 business days of the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Kidney Transplant in Kidney Transplant Rejection
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Kidney Transplant in Kidney Transplant Rejection report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Kidney Transplant in Kidney Transplant Rejection Drug Details: The therapeutic...